Navigation Links
PTC Therapeutics Announces Additional Positive Interim Phase 2,Results of PTC124 in Duchenne Muscular Dystrophy

nd teachers reported that boys participating in the study had improvements in terms of greater activity level and increased endurance during treatment. Individual subjects at both dose levels demonstrated some improvements in upper and lower muscle strength however in the overall analysis the magnitude of change was not statistically significant.

PTC124 was well tolerated among the 26 patients included in the study. Adverse events were infrequent, mild to moderate in severity, and did not result in therapy interruptions or discontinuations. There were no safety concerns based on physical examinations, vital sign measurements, electrocardiograms or laboratory parameters. Compliance with PTC124 treatment was excellent at both dose levels.

Stuart W. Peltz, Ph.D., President and Chief Executive Officer of PTC Therapeutics, stated, "In addition to the clinical proof-of-concept data we disclosed late last year, these new insights provide us with further evidence supporting the potential of PTC124 in genetic disorders due to a nonsense mutation. The findings in the DMD trials are consistent with the results observed in Phase 2 clinical trials of PTC124 in patients with cystic fibrosis and with preclinical results in the DMD mouse model that were recently published in Nature. We are eager to extend testing of this concept into other nonsense-mediated genetic disorders."

About Duchenne Muscular Dystrophy

Duchenne muscular dystrophy (DMD) is a progressive muscle disorder that causes the loss of both muscle function and independence. DMD is perhaps the most prevalent of the muscular dystrophies and is the most common lethal genetic disorder diagnosed during childhood today. Each year, approximately 20,000 children worldwide are born with DMD (one of every 3,500 male children). More information regarding DMD is available through the Muscular Dystrophy Association (www.mdausa.org) and the Parent Pro
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
2. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
3. CV Therapeutics Identifies Potential Anti-Diabetic Mechanism of Action for Ranexa
4. Fat Kills Cancer: Turning Stem Cells from Fat Tissue into Personalized, Cancer-Targeted Therapeutics
5. A 4-Week Therapy with Transition Therapeutics E1-I.N.T. Leads to Sustained Reductions in Blood Glucose Levels for 6 Months Post-treatment in Type 2 Diabetes Patients
6. Clinical Trial Suggests Bone Marrow Stem Cells Are Useful for Spinal Cord Injury; PrimeCell Therapeutics Provided Pre-Clinical Study
7. Opexa Therapeutics Reports Positive Top-line Data in Phase I/II Extension Trial with Tovaxin for Multiple Sclerosis
8. Orexigen Therapeutics to Present Data on Contrave Impact on Visceral Fat and Insulin Resistance at American Diabetes Association 67th Scientific Sessions in Chicago June 23
9. Allos Therapeutics Reports Results for Phase 3 Enrich Study of Efaproxyn in Women With Brain Metastases Originating From Breast Cancer
10. Trophos Publishes ALS Article in Journal of Pharmacology and Experimental Therapeutics
11. Novelos Therapeutics Announces Encouraging Results in Ongoing Phase 2 Ovarian Cancer Trial at Dana-Farber/Partners Cancer Care
Post Your Comments:
(Date:3/31/2015)... YORK , March 31, 2015 Immune ... announced today that it intends to expand its planned ... human monoclonal antibody targeting eotaxin-1. Bullous Pemphigoid is an ... 60,000 patients in the US and Europe ... to start enrolling patients in a Phase II clinical ...
(Date:3/31/2015)...  CVS Health (NYSE: CVS ) announced ... with Rush University Medical Center in ... in Tucson, Arizona and ... affiliations will help enhance access to high-quality, affordable ... affiliations, CVS Health will provide prescription and visit ...
(Date:3/31/2015)... , Mar. 27, 2015 Research and Markets ... addition of the "European Laboratory Information System ... by Type (Clinical Pathology Laboratory Information System, Anatomic ... report to their offering. The ... grow at a CAGR of 7.6% from 2014 ...
Breaking Medicine Technology:Immune Pharmaceuticals To Expand Bullous Pemphigoid Clinical Development Plan For Bertilimumab 2Immune Pharmaceuticals To Expand Bullous Pemphigoid Clinical Development Plan For Bertilimumab 3Immune Pharmaceuticals To Expand Bullous Pemphigoid Clinical Development Plan For Bertilimumab 4CVS Health Announces New Clinical Affiliations with Leading Medical Centers in Arizona and Illinois 2CVS Health Announces New Clinical Affiliations with Leading Medical Centers in Arizona and Illinois 3European Laboratory Information System Market Report 2015: Germany holds a larger share of the laboratory information systems market 2European Laboratory Information System Market Report 2015: Germany holds a larger share of the laboratory information systems market 3
(Date:3/31/2015)... Scotch Plains, NJ (PRWEB) March 31, 2015 ... breast care to all patients in a calm and caring ... specialists in the diagnosis and surgical treatment of breast cancer. ... the tri-state area but from all over the world. ... national and local publications. , The seeds for Summit Breast ...
(Date:3/31/2015)... Researchers at UC Davis have ... how human livers heal. The difference centers on ... Normally, mouse PPARa is far more active and ... quickly regenerate damaged livers. However, the research shows ... boost the regenerative effects of human PPARa. The ...
(Date:3/31/2015)... Portland, OR (PRWEB) March 31, 2015 Former ... retirement announcement than during his first year of a promising ... , Sports on Earth Senior Writer Will Leitch ... on the league. Leitch talks about the decision making process ... choosing the preservation of health over a large paycheck, and ...
(Date:3/31/2015)... Exton, PA (PRWEB) March 31, 2015 ... to the physical, social and psychological benefits of ... about the thousands of adaptive sports athletes that ... United States, encourage support for inclusive fitness and ... individuals interested in participating in adaptive sports and ...
(Date:3/31/2015)... 2015 Nutrition 21, LLC (“Nutrition ... new clinical study results supporting the efficacy of ... “Arginine Silicate Supplementation Decreases Markers of Cardiovascular, Renal ... and Cardiovascular Health in Healthy Adult Males.” The ... at the acclaimed Experimental Biology 2015 annual meeting ...
Breaking Medicine News(10 mins):Health News:Summit Breast Care is Celebrating Four Years as "NJ Top Docs" 2Health News:UC Davis Study Finds Protein May Improve Liver Regeneration 2Health News:UC Davis Study Finds Protein May Improve Liver Regeneration 3Health News:UC Davis Study Finds Protein May Improve Liver Regeneration 4Health News:Will Leitch and the Curious Case of Chris Borland on SCI TV 2Health News:Will Leitch and the Curious Case of Chris Borland on SCI TV 3Health News:April is National Adaptive Sports Month 2Health News:April is National Adaptive Sports Month 3Health News:Nutrition 21, LLC Announces the Presentation of Proteomic Results of a Nitrosigine® Clinical Study at the Renowned Experimental Biology 2015 Annual Meeting 2Health News:Nutrition 21, LLC Announces the Presentation of Proteomic Results of a Nitrosigine® Clinical Study at the Renowned Experimental Biology 2015 Annual Meeting 3Health News:Nutrition 21, LLC Announces the Presentation of Proteomic Results of a Nitrosigine® Clinical Study at the Renowned Experimental Biology 2015 Annual Meeting 4Health News:Nutrition 21, LLC Announces the Presentation of Proteomic Results of a Nitrosigine® Clinical Study at the Renowned Experimental Biology 2015 Annual Meeting 5Health News:Nutrition 21, LLC Announces the Presentation of Proteomic Results of a Nitrosigine® Clinical Study at the Renowned Experimental Biology 2015 Annual Meeting 6
... , - Misys BankFusion Universal Banking at the ... MSY.L), the global application software and services,company, today announces ... Banking., Government owned until 1996, CRDB Bank is ... 10 new branches a year, launch a fully,automated and ...
... with proven results. Women have seen increases of ½ to 2 ... comes from a blend of 13 different herbs, all of which ... effective for natural breast enhancement. , ... Port St. ...
... Intelligent Document Solutions to Speed Up Vision Plan ... Claim Processes, Improves ... August 18 /PRNewswire-FirstCall/,-- Autonomy Corporation plc (LSE: AU. ... the enterprise, today announced that General,Vision Services (GVS) ...
... of interpersonal conflict have a three-fold greater risk of ... to a new study by University of California, Davis, ... have never had a diagnosis of depression. , ... (EDT) poster session, "Improving Our Practice -- ,Focus on ...
... urged psychologists today to take a leading role ... upon the profession to provide "appropriate, nondiscriminatory treatment ... more research into all aspects of gender identity ... Annual Convention when the association,s governing Council of ...
... high performance mass spectrometry products and applications for proteomics at the ... ... The Netherlands (Business Wire EON) August 17, 2008 -- maXis™ ... mass spectrometer platform, and truly represents a revolution in tandem mass ...
Cached Medicine News:Health News:CRDB Bases Growth Strategy on Misys BankFusion Platform 2Health News:CRDB Bases Growth Strategy on Misys BankFusion Platform 3Health News:Zoft Breast Enhancement Gum Revolutionizes Breast Enhancement Industry 2Health News:Zoft Breast Enhancement Gum Revolutionizes Breast Enhancement Industry 3Health News:General Vision Services Standardizes on Autonomy to Automate Third-Party Administration Processes for Vision Care Services 2Health News:General Vision Services Standardizes on Autonomy to Automate Third-Party Administration Processes for Vision Care Services 3Health News:General Vision Services Standardizes on Autonomy to Automate Third-Party Administration Processes for Vision Care Services 4Health News:Suicide in Asian Americans 2Health News:APA resolves to play leading role in improving treatment for gender-variant people 2Health News:APA resolves to play leading role in improving treatment for gender-variant people 3Health News: Bruker Daltonics Showcasing Novel Proteomics Solutions Based on Mass Spectrometry at the 7th HUPO World Congress 2008 2Health News: Bruker Daltonics Showcasing Novel Proteomics Solutions Based on Mass Spectrometry at the 7th HUPO World Congress 2008 3Health News: Bruker Daltonics Showcasing Novel Proteomics Solutions Based on Mass Spectrometry at the 7th HUPO World Congress 2008 4
... a concise yet complete eTextbook of ... cardiovascular disease. In addition to the ... a full desktop version is included ... to the electronic textbook, Redi-Reference provides ...
ECG pocket is a handy reference for identifying common ECG findings....
... Reviews enable all those involved with healthcare ... the very latest evidence in their field ... harder each year as the volume of ... by delivering the best single source available ...
... Anatomy Flash Cards is ... the heart, veins, and ... system. It uses the ... images from BryanEdwards.com and ...
Medicine Products: